ArticleScience advances2026
Electronics-free soft robotic minitablet for on-demand gastric molecular sensing and diagnostics in vivo.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biohybrid magnetic carrier robots for targeted bacteria release in ulcerative colitis.Materials today. Bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Real-time biomarker sensing and molecular sampling in the stomach can transform how gastrointestinal disorders are diagnosed and managed-yet integrating both capabilities into a single ingestible platform remains a formidable challenge. Existing devices often struggle with size constraints, limited functionality, and the mechanical mismatch between soft, biocompatible materials and rigid electronics. Here, we present SeroTab, an electronics-free soft robotic minitablet that combines real-time pH sensing with on-demand gastric fluid sampling in vivo. Inspired by the gliding motion of penguins through viscous environments, SeroTab features a magnetically actuated, curvature-adaptive body that enables autonomous navigation through complex anatomical geometries to specific gastric regions. Upon reaching its target, a shape memory polymer actuator-triggered wirelessly via radio frequency heating-draws gastric fluid into an internal reservoir (up to 35 microliters). A pH-sensitive hydrogel within the chamber, embedded with biocompatible metal disks, enables ultrasound-based pH readout across a physiologically relevant range (pH 2 to 7) and preserves the sample for untargeted metabolomic profiling. In vivo studies in animal models demonstrate SeroTab's ability to detect pharmacologically induced pH changes (ΔpH = 4, from 2 to 6) and metabolic shifts (42 detected metabolites) following omeprazole administration. By uniting soft robotics, responsive materials, and wireless actuation, SeroTab paves the way for minimally invasive, outpatient-compatible diagnostics that can advance early screening and streamline clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.